Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2006

Open Access 01-12-2006 | Research article

Municipal distribution of bladder cancer mortality in Spain: Possible role of mining and industry

Authors: Gonzalo Lopez-Abente, Nuria Aragones, Rebeca Ramis, Valentin Hernandez-Barrera, Beatriz Perez-Gomez, Antonio Escolar-Pujolar, Marina Pollan

Published in: BMC Public Health | Issue 1/2006

Login to get access

Abstract

Background

Spain shows the highest bladder cancer incidence rates in men among European countries. The most important risk factors are tobacco smoking and occupational exposure to a range of different chemical substances, such as aromatic amines.

Methods

This paper describes the municipal distribution of bladder cancer mortality and attempts to "adjust" this spatial pattern for the prevalence of smokers, using the autoregressive spatial model proposed by Besag, York and Molliè, with relative risk of lung cancer mortality as a surrogate.

Results

It has been possible to compile and ascertain the posterior distribution of relative risk for bladder cancer adjusted for lung cancer mortality, on the basis of a single Bayesian spatial model covering all of Spain's 8077 towns. Maps were plotted depicting smoothed relative risk (RR) estimates, and the distribution of the posterior probability of RR>1 by sex. Towns that registered the highest relative risks for both sexes were mostly located in the Provinces of Cadiz, Seville, Huelva, Barcelona and Almería. The highest-risk area in Barcelona Province corresponded to very specific municipal areas in the Bages district, e.g., Suría, Sallent, Balsareny, Manresa and Cardona.

Conclusion

Mining/industrial pollution and the risk entailed in certain occupational exposures could in part be dictating the pattern of municipal bladder cancer mortality in Spain. Population exposure to arsenic is a matter that calls for attention. It would be of great interest if the relationship between the chemical quality of drinking water and the frequency of bladder cancer could be studied.
Appendix
Available only for authorised users
Literature
1.
Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003, 14 (Suppl 5): v128-v149. 10.1093/annonc/mdg756.CrossRefPubMed
2.
Lawson A, Biggeri A, Bohning D, Lesaffre E, Biggeri A, Viel JF, et al: Disease mapping and risk assessment for public health. 1999, Chichester: Wiley
3.
Elliott P, Wakefield JC, Best N, Briggs S: Spatial epidemiology. 2000, New York: Oxford
4.
Richardson S, Thomson A, Best N, Elliott P: Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect. 2004, 112: 1016-1025.CrossRefPubMedPubMedCentral
5.
Lopez-Abente G, Gonzalez CA, Errezola M, Escolar A, Izarzugaza I, Nebot M, Riboli E: Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. Am J Epidemiol. 1991, 134: 830-839.PubMed
6.
Silverman DT, Hartge P, Morrison AS, Devesa SS: Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 1992, 6: 1-30.PubMed
7.
Gonzalez CA, Lopez-Abente G, Errezola M, Escolar A, Riboli E, Izarzugaza I, Nebot M: Occupation and bladder cancer in Spain: a multi-centre case-control study. Int J Epidemiol. 1989, 18: 569-577.CrossRefPubMed
8.
Kogevinas M, Mannetje A., Cordier S, Ranft U, Gonzalez CA, Vineis P, Chang-Claude J, Lynge E, Wahrendorf J, Tzonou A, Jockel KH, Serra C, Porru S, Hours M, Greiser E, Boffetta P: Occupation and bladder cancer among men in Western Europe. Cancer Causes Control. 2003, 14: 907-914. 10.1023/B:CACO.0000007962.19066.9c.CrossRefPubMed
9.
Chen CJ, Chuang YC, You SL, Lin TM, Wu HY: A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer. 1986, 53: 399-405.CrossRefPubMedPubMedCentral
10.
Smith AH, Goycolea M, Haque R, Biggs ML: Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998, 147: 660-669.CrossRefPubMed
11.
Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JS, Huang CH, Chen CJ: Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995, 55: 1296-1300.PubMed
12.
Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y, Aoyama H: Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 1995, 141: 198-209.PubMed
13.
Hopenhayn-Rich C, Biggs ML, Smith AH: Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 1998, 27: 561-569. 10.1093/ije/27.4.561.CrossRefPubMed
14.
Villanueva CM, Cantor KP, Cordier S, Jaakkola JJ, King WD, Lynch CF, Porru S, Kogevinas M: Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology. 2004, 15: 357-367. 10.1097/01.ede.0000121380.02594.fc.CrossRefPubMed
15.
Llobet JM, Falco G, Casas C, Teixido A, Domingo JL: Concentrations of arsenic, cadmium, mercury, and lead in common foods and estimated daily intake by children, adolescents, adults, and seniors of Catalonia, Spain. J Agric Food Chem. 2003, 51: 838-842. 10.1021/jf020734q.CrossRefPubMed
16.
Bordajandi LR, Gomez G, Abad E, Rivera J, Mar Fernandez-Baston M, Blasco J, Gonzalez MJ: Survey of persistent organochlorine contaminants (PCBs, PCDD/Fs, and PAHs), heavy metals (Cu, Cd, Zn, Pb, and Hg), and arsenic in food samples from Huelva (Spain): levels and health implications. J Agric Food Chem. 2004, 52: 992-1001. 10.1021/jf030453y.CrossRefPubMed
17.
Urieta I, Jalon M, Eguilero I: Food surveillance in the Basque Country (Spain). II. Estimation of the dietary intake of organochlorine pesticides, heavy metals, arsenic, aflatoxin M1, iron and zinc through the Total Diet Study, 1990/91. Food Addit Contam. 1996, 13: 29-52.CrossRefPubMed
18.
Delgado-Andrade C, Navarro M, Lopez H, Lopez MC: Determination of total arsenic levels by hydride generation atomic absorption spectrometry in foods from south-east Spain: estimation of daily dietary intake. Food Addit Contam. 2003, 20: 923-932. 10.1080/02652030310001594450.CrossRefPubMed
19.
Herce-Pagliai C, Moreno I, Gonzalez G, Repetto M, Camean AM: Determination of total arsenic, inorganic and organic arsenic species in wine. Food Addit Contam. 2002, 19: 542-546. 10.1080/02652030110113762.CrossRefPubMed
20.
Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D: Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol. 2004, 160: 853-859. 10.1093/aje/kwh295.CrossRefPubMed
21.
Clayton D, Kaldor J: Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics. 1987, 43: 671-681.CrossRefPubMed
22.
Besag J, York J, Molliè A, Besag J, York JC, Mollie A: Bayesian image restoration, with two applications in spatial statistics (with discussion). Annals of the Institute of Statistical Mathematics. 1991, 43: 1-59. 10.1007/BF00116466.CrossRef
23.
Clayton DG, Bernardinelli L, Montomoli C: Spatial correlation in ecological analysis. Int J Epidemiol. 1993, 22: 1193-1202.CrossRefPubMed
24.
Gilks W, Richardson S, Spiegelhalter D: Markov Chain Monte Carlo in Practice. Interdisciplinary Statistics. 1995, Boca Raton, Florida: Chapman & Hall/CRC
25.
Spiegelhalter D, Thomas A, Best N, Lunn D: WinBUGS user manual. Version 1.4.1. 2003, Cambridge: MRC
26.
27.
Lopez-Abente G, Pollán M, Aragones N, Pérez B, Llácer A, Pérez J, et al: Tendencias de la mortalidad en España, 1952–1996. Efecto de la edad, de la cohorte de nacimiento y del periodo de muerte. 2002, Madrid: Instituto de Salud Carlos III
28.
Ferlay J, Bray F, Sankila R, Parkin D: EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1998, version 5.0. 1999, Lyon
29.
Villanueva CM, Fernandez F, Malats N, Grimalt JO, Kogevinas M: Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health. 2003, 57: 166-173. 10.1136/jech.57.3.166.CrossRefPubMedPubMedCentral
30.
IARC (International Agency for Research on Cancer): IARC monographs on the evaluation of carcinogenic risks to humans: overall evaluations of carcinogenicity. An updating of IARC monographs volumes 1 to 42. 1987, Lyon: International Agency for Research on Cancer
31.
EPA (Environmental Protection Agency): Risk assessment forum. Special report on ingested inorganic arsenic: skin cancer, nutrition essentiality. 1988, Washington, DC: Environmental Protection Agency
32.
Wu MM, Kuo TL, Hwang YH, Chen CJ: Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989, 130: 1123-1132.PubMed
33.
Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH: Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996, 7: 117-124.CrossRefPubMed
34.
Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest. 2003, 123: 21S-49S. 10.1378/chest.123.1_suppl.21S.CrossRefPubMed
35.
Langford IH, Leyland AH, Rasbash J, Goldstein H: Multilevel modelling of the geographical distributions of diseases. J R Stat Soc Ser C Appl Stat. 1999, 48: 253-268. 10.1111/1467-9876.00153.CrossRefPubMed
36.
Leyland AH, Langford IH, Rasbash J, Goldstein H: Multivariate spatial models for event data. Stat Med. 2000, 19: 2469-2478. 10.1002/1097-0258(20000915/30)19:17/18<2469::AID-SIM582>3.0.CO;2-4.CrossRefPubMed
37.
Knorr-Held L, Best N: A shared component model for detecting joint and selective clustering of two diseases. Journal of the Royal Statistical Society, Series A. 2001, 164: 73-86.CrossRef
38.
Held L, Natario I, Fenton SE, Rue H, Becker N: Towards joint disease mapping. Stat Methods Med Res. 2005, 14: 61-82. 10.1191/0962280205sm389oa.CrossRefPubMed
39.
Dabney AR, Wakefield JC: Issues in the mapping of two diseases. Stat Methods Med Res. 2005, 14: 83-112. 10.1191/0962280205sm340oa.CrossRefPubMed
40.
CSIC (Consejo Superior de Investigaciones Científicas): Informes del estudio sobre el diagnóstico ambiental y sanitario de la ría de Huelva. Segundo informe del estudio que coordina el Consejo Superior de Investigaciones Científicas sobre el diagnóstico ambiental y sanitario de la ría de Huelva. 2005, [http://​www.​csic.​es/​wi/​informes_​csic.​jsp]
41.
Sanzo JM, Dorronsoro M, Amiano P, Amurrio A, Aguinagalde FX, Azpiri MA: Estimation and validation of mercury intake associated with fish consumption in an EPIC cohort of Spain. Public Health Nutr. 2001, 4: 981-988.CrossRefPubMed
42.
Schuhmacher M, Batiste J, Bosque MA, Domingo JL, Corbella J: Mercury concentrations in marine species from the coastal area of Tarragona Province, Spain. Dietary intake of mercury through fish and seafood consumption. Sci Total Environ. 1994, 156: 269-273. 10.1016/0048-9697(94)90193-7.CrossRefPubMed
43.
Welch AA, Lund E, Amiano P, Dorronsoro M, Brustad M, Kumle M, Rodriguez M, Lasheras C, Janzon L, Jansson J, Luben R, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Klipstein-Grobusch K, Benetou V, Zavitsanos X, Tumino R, Galasso R, Bueno-De-Mesquita HB, Ocke MC, Charrondiere UR, Slimani N: Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2002, 5: 1273-1285. 10.1079/PHN2002404.CrossRefPubMed
44.
Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 2004, 15: 465-472. 10.1023/B:CACO.0000036452.55199.a3.CrossRefPubMed
45.
Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH: Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol. 2004, 159: 381-389. 10.1093/aje/kwh054.CrossRefPubMed
46.
47.
Nadal J: Moler, tejer y fundir. Estudios de historia industrial. 1992, Barcelona: Ariel
48.
Serra C, Bonfill X, Sunyer J, Urrutia G, Turuguet D, Bastus R, Roque M, 't MA, Kogevinas M: Bladder cancer in the textile industry. Scand J Work Environ Health. 2000, 26: 476-481.CrossRefPubMed
49.
Mannetje A, Kogevinas M, Chang-Claude J, Cordier S, Gonzalez CA, Hours M, Jockel KH, Bolm-Audorff U, Lynge E, Porru S, Donato F, Ranft U, Serra C, Tzonou A, Vineis P, Wahrendorf J, Boffetta P: Occupation and bladder cancer in European women. Cancer Causes Control. 1999, 10: 209-217. 10.1023/A:1008852127139.CrossRefPubMed
50.
Mastrangelo G, Fedeli U, Fadda E, Milan G, Lange JH: Epidemiologic evidence of cancer risk in textile industry workers: a review and update. Toxicol Ind Health. 2002, 18: 171-181. 10.1191/0748233702th139rr.CrossRefPubMed
51.
Luster MI, Simeonova PP: Arsenic and urinary bladder cell proliferation. Toxicol Appl Pharmacol. 2004, 198: 419-423. 10.1016/j.taap.2003.07.017.CrossRefPubMed
52.
Aragones SN, Palacios DM, Avello dM, Gomez RP, Martinez CM, Rodriguez Bernabeu MJ: [Arsenic levels in drinking water supplies from underground sources in the community of Madrid]. Rev Esp Salud Publica. 2001, 75: 421-432.
53.
Smith AH, Lopipero PA, Bates MN, Steinmaus CM: Public health. Arsenic epidemiology and drinking water standards. Science. 2002, 296: 2145-2146. 10.1126/science.1072896.CrossRefPubMed
54.
55.
Edlich RF, Winters KL, Long WB: Treated wood preservatives linked to aquatic damage, human illness, and death – a societal problem. J Long Term Eff Med Implants. 2005, 15: 209-223. 10.1615/JLongTermEffMedImplants.v15.i2.80.CrossRefPubMed
56.
Belluck DA, Benjamin SL, Baveye P, Sampson J, Johnson B: Widespread arsenic contamination of soils in residential areas and public spaces: an emerging regulatory or medical crisis?. Int J Toxicol. 2003, 22: 109-128. 10.1080/10915810305087.CrossRefPubMed
Metadata
Title
Municipal distribution of bladder cancer mortality in Spain: Possible role of mining and industry
Authors
Gonzalo Lopez-Abente
Nuria Aragones
Rebeca Ramis
Valentin Hernandez-Barrera
Beatriz Perez-Gomez
Antonio Escolar-Pujolar
Marina Pollan
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2006
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-6-17

Other articles of this Issue 1/2006

BMC Public Health 1/2006 Go to the issue

Research article

An examination of knowledge, attitudes and practices related to lead exposure in South Western Nigeria

Research article

Changes in Scottish suicide rates during the Second World War

Research article

Design and descriptive results of the "Growth, Exercise and Nutrition Epidemiological Study In preSchoolers": The GENESIS Study

Research article

Does a competitive voucher program for adolescents improve the quality of reproductive health care? A simulated patient study in Nicaragua

Research article

Changes in the incidence of occupational disability as a result of back and neck pain in the Netherlands

Research article

The impact of ambient temperature on mortality among the urban population in Skopje, Macedonia during the period 1996–2000